Determination of BRCAness phenotype in breast tumors for the appointment of neoadjuvant chemotherapy based on platinum and taxanes
The concept of BRCAness was developed because of similarities between sporadic and hereditary breast cancer. BRCAness defines the pathogenesis and treatment sensitivity of many types of cancer, as well as the presence of a defect in the homologous recombination repair of tumor cells simulating the l...
| Published in: | International journal of molecular sciences Vol. 24, № 1. P. 207 (1-13) |
|---|---|
| Other Authors: | Tsyganov, Matvey M., Ibragimova, Marina K., Garbukov, Evgeny Yu, Bragina, Olga D., Karchevskaya, Ariana A., Usynin, Evgeny A., Litvyakov, Nicolay V. |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | http://vital.lib.tsu.ru/vital/access/manager/Repository/koha:001009372 |
Similar Items
- Mutations of BRCA1, BRCA2, and PALB2 genes in breast tumor tissue: Relationship with the effectiveness of neoadjuvant chemotherapy and disease prognosis
- Исследование связи потери гетерозиготности с безметастатической выживаемостью в опухолевой ткани молочной железы
- Microarray analysis of DNA copy number aberration of the BRCA1 gene in breast tumor: correlation with the efficacy of neoadjuvant chemotherapy
- DNA copy number aberrations and expression of ABC transporter genes in breast tumour: Correlation with the effect of neoadjuvant chemotherapy and prognosis of the disease
- Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients
